Axsome Therapeutics Inc. (AXSM)
NASDAQ: AXSM
· Real-Time Price · USD
109.20
0.45 (0.41%)
At close: Aug 15, 2025, 3:59 PM
108.00
-1.10%
After-hours: Aug 15, 2025, 07:57 PM EDT
Axsome Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 495.03M | 432.16M | 385.69M | 338.46M | 291.49M | 251.02M | 270.6M | 223.44M | 182.49M | 144.61M | 50.04M | 25.67M | 8.82M | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 42.19M | 36.8M | 35.13M | 32M | 30.09M | 26.64M | 26.07M | 20.98M | 16.37M | 12.75M | 5.51M | 3.53M | 1.9M | 1.2M | 892.9K | 585.49K | 285.75K | 8.33K |
Gross Profit | 452.85M | 395.36M | 350.56M | 306.46M | 261.4M | 224.39M | 244.53M | 202.46M | 166.12M | 131.86M | 44.53M | 22.14M | 6.92M | -1.2M | -892.9K | -585.49K | -285.75K | -8.33K |
Operating Income | -228.94M | -270.27M | -281.97M | -307.47M | -306.96M | -293.98M | -231.82M | -189.43M | -169.76M | -144.75M | -176.5M | -153.39M | -144.35M | -135.15M | -124.71M | -119.84M | -107.56M | -94.49M |
Interest Income | 4.74M | 4.74M | 4.74M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -247.78M | -278.19M | -287.13M | -311.28M | -309.56M | -298M | -238.28M | -200.54M | -182.49M | -156.14M | -187.13M | -159.87M | -149.93M | -140.78M | -130.4M | -125.59M | -113.63M | -99.68M |
Net Income | -246.9M | -278.27M | -287.22M | -310.95M | -308.55M | -296.38M | -239.24M | -207.35M | -192.38M | -168.05M | -197.81M | -165.02M | -152.67M | -142.12M | -130.4M | -125.59M | -113.63M | -99.68M |
Selling & General & Admin | 459.9M | 433.18M | 411.36M | 384.9M | 372.52M | 347.9M | 323.12M | 297.81M | 255.52M | 207.74M | 159.25M | 116.58M | 95.92M | 81.1M | 66.65M | 58.18M | 44.28M | 35.18M |
Research & Development | 194.96M | 195.27M | 187.08M | 162.63M | 146.01M | 116.74M | 97.94M | 81.83M | 67.94M | 63.16M | 57.95M | 57.04M | 55.34M | 54.05M | 58.06M | 61.66M | 63.28M | 59.32M |
Other Expenses | 33.67M | 37.42M | 34.52M | 72.63M | 56.06M | 59.95M | 61.35M | 12.25M | 12.43M | 5.71M | 4.14M | 2.53M | 925.65K | n/a | n/a | -53.58K | -53.58K | -53.58K |
Operating Expenses | 688.71M | 666.05M | 632.95M | 619.98M | 574.41M | 518.36M | 476.36M | 385.84M | 329.83M | 276.61M | 221.34M | 176.15M | 152.18M | 135.15M | 124.71M | 119.79M | 107.51M | 94.44M |
Interest Expense | 4.66M | 7.8M | 11.31M | 5.06M | 3.84M | 5.27M | 6.45M | 7.07M | 8.73M | 8.26M | 7.33M | 7.38M | 6.44M | 5.62M | 5.7M | 5.8M | 4.88M | 3.99M |
Selling & Marketing Expenses | -54.3M | -24M | n/a | 78.4M | 106.5M | 102.9M | 100.3M | 39.94M | 11.84M | -14.86M | -36.26M | -583 | -140 | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 729.07M | 701.01M | 666.25M | 651.98M | 604.51M | 545M | 502.43M | 406.82M | 346.2M | 289.36M | 226.54M | 179.06M | 153.16M | 135.15M | 124.71M | 119.79M | 107.51M | 94.44M |
Income Tax Expense | -875K | 85K | 85K | -3.6M | -2.92M | -3.54M | -960K | 8.16M | 9.9M | 11.91M | 10.67M | 5.15M | 2.74M | 1.34M | 262.76K | 255.11K | 255.11K | 255.11K |
Shares Outstanding (Basic) | 49.44M | 48.87M | 48.54M | 48.14M | 47.57M | 47.39M | 47.33M | 47.12M | 43.67M | 43.52M | 43.45M | 41.7M | 39.08M | 38.32M | 37.76M | 37.68M | 37.6M | 37.43M |
Shares Outstanding (Diluted) | 49.44M | 48.87M | 48.54M | 48.14M | 47.57M | 47.39M | 47.33M | 47.12M | 43.67M | 43.52M | 43.45M | 41.7M | 39.08M | 38.32M | 37.76M | 37.68M | 37.6M | 37.43M |
EPS (Basic) | -5.07 | -5.77 | -5.99 | -6.53 | -6.51 | -6.38 | -5.2 | -4.66 | -4.47 | -4.03 | -4.84 | -4.2 | -4 | -3.76 | -3.47 | -3.35 | -3.03 | -2.66 |
EPS (Diluted) | -5.07 | -5.77 | -5.99 | -6.53 | -6.51 | -6.38 | -5.2 | -4.66 | -4.47 | -4.03 | -4.84 | -4.2 | -4 | -3.76 | -3.47 | -3.35 | -3.03 | -2.66 |
EBITDA | -224.8M | -266.13M | -274.6M | -300.59M | -300.4M | -285.26M | -224.53M | -185.9M | -165.97M | -140.97M | -174.23M | -148.64M | -141.29M | -133.96M | -123.81M | -119.2M | -108.46M | -95.66M |
EBIT | -244.18M | -275.13M | -280.56M | -306.22M | -305.71M | -292.73M | -231.82M | -193.47M | -173.76M | -147.88M | -179.8M | -152.49M | -143.49M | -135.15M | -124.71M | -119.79M | -108.76M | -95.69M |
Depreciation & Amortization | 9M | 10.99M | 7.96M | 7.63M | 7.65M | 7.8M | 7.95M | 8.23M | 8.1M | 7.23M | 5.56M | 3.85M | 2.19M | 1.2M | 892.9K | 646.73K | 352.51K | 80.61K |